← The SEC Ephemeris: the whole map
UGB, Inc. UCB4940
In the graph: all 1 documents (2 pages).
- Application
- BLA 761151
- Ticker
- UGB, Inc.
- Product
- UCB4940
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- May 12, 2022
From FDA letters and SEC filings. Not investment or medical advice.